Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas
- 1 February 1997
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 181 (2) , 140-145
- https://doi.org/10.1002/(sici)1096-9896(199702)181:2<140::aid-path745>3.0.co;2-a
Abstract
Alterations in the p53 protein are a common feature in most malignancies, including breast carcinomas. p53 protein alterations contribute to malignant transformation in several ways, through genomic instability and accumulation of additional genetic alterations in other genes, through alteration of the p53-dependent apoptotic pathway, and through downregulation of downstream effector proteins such as p21 (WAF1/CIP1), necessary for cell-cycle growth arrest. Cell-cycle arrest is needed to allow DNA repair after injury. This study examines the relationship between abnormalities in p53 protein and expression of p21 protein in 70 cases selected from a series of 212 sporadic human breast carcinomas. Immunohistochemistry (IHC) was used for detection of p53 and p21 protein expression. Constant denaturant gel electrophoresis (CDGE) was used for detection of mutations in exons 5–8 of the TP53 gene. A highly significant association was found between abnormalities in p53, scored as protein accumulation and/or mutations, and lack of p21 expression. p21 was also shown to be downregulated in samples without p53 alterations, indicating that other mechanisms are also involved in turning off this gene. © 1997 John Wiley & Sons, Ltd.Keywords
This publication has 15 references indexed in Scilit:
- Alterations of the TP53 Gene as a Potential Prognostic Marker in Breast CarcinomasDiagnostic Molecular Pathology, 1995
- Genomic instability and the role of p53 mutations in cancer cellsCurrent Opinion in Oncology, 1995
- Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard.Proceedings of the National Academy of Sciences, 1994
- Prognostic significance of TP53 alterations in breast carcinomaBritish Journal of Cancer, 1993
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- Accumulation of p53 Protein as an Indicator for p53 Gene Mutation in Breast CancerDiagnostic Molecular Pathology, 1993
- A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasiaCell, 1992
- Creative blocks: cell-cycle checkpoints and feedback controlsNature, 1992
- Checkpoints: Controls That Ensure the Order of Cell Cycle EventsScience, 1989
- A Comparative Study of the Peroxidase-antiperoxidase Method and an Avidin-Biotin Complex Method for Studying Polypeptide Hormones with Radioimmunoassay AntibodiesAmerican Journal of Clinical Pathology, 1981